Product Information
DICLOFENAC-MISOPROSTOL DR 75-0.2 MG TABLET is a generic product labeled by Mylan Pharmaceuticals Inc., priced at $0.9662 per EA under NDC 59762002901. Its NADAC has been published 671 times since Nov 28, 2013.
FDA first approved this application on Dec 24, 1997. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
75; 200 mg/1; ug/1
Manufacturer
Mylan Pharmaceuticals Inc.NDC
59762002901
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
DICLOFENAC SODIUM; MISOPROSTOLApproval Type
Authorized Generic (NDA)
FDA Application
NDA020607FDA Approved
12/24/1997
TE Code
AB
On Market Since
11/1/2012
Pharmacological Classes
Price Statistics
The NADAC for DICLOFENAC-MISOPROSTOL DR 75-0.2 MG TABLET has been published 671 times since Nov 28, 2013, and over the history we have for it it has declined 58.4%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.9662 per EA |
|---|---|
| All-time high | $2.4670 (Mar 12, 2014) |
| All-time low | $0.7254 (Nov 20, 2024) |
| 52-week high | $1.0906 |
| 52-week low | $0.9418 |
| Median price | $1.7250 |
| Average price | $1.6843 |
| Largest weekly change | -39.0% (Nov 20, 2024) |
| Weeks tracked | 671 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the Diclofenac sodium and Misoprostol market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Mylan Pharmaceuticals Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Diclofenac sodium and Misoprostol market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Nonsteroidal Anti-inflammatory Drug class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of DICLOFENAC-MISOPROSTOL DR 75-0.2 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for DICLOFENAC-MISOPROSTOL DR 75-0.2 MG TABLET, manufactured by Mylan Pharmaceuticals Inc., is $0.9662 per EA (NDC 59762002901), effective Sep 30, 2026.
How has the price of DICLOFENAC-MISOPROSTOL DR 75-0.2 MG TABLET changed over time?
Over the history we have for it, the NADAC for DICLOFENAC-MISOPROSTOL DR 75-0.2 MG TABLET has declined 58.4%. It has been tracked across 671 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for DICLOFENAC-MISOPROSTOL DR 75-0.2 MG TABLET?
Since Nov 28, 2013, the NADAC for DICLOFENAC-MISOPROSTOL DR 75-0.2 MG TABLET has ranged from a low of $0.7254 (Nov 20, 2024) to a high of $2.4670 (Mar 12, 2014), with a median of $1.7250 per EA.
Are there cheaper alternatives to DICLOFENAC-MISOPROSTOL DR 75-0.2 MG TABLET?
No other NADAC-published product currently shares the active ingredient and strength of DICLOFENAC-MISOPROSTOL DR 75-0.2 MG TABLET in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures DICLOFENAC-MISOPROSTOL DR 75-0.2 MG TABLET?
DICLOFENAC-MISOPROSTOL DR 75-0.2 MG TABLET (NDC 59762002901) is labeled by Mylan Pharmaceuticals Inc., and CMS classifies it as a generic product.